Onyx Biotec Peer Comparison

NSE: ONYX

₹36.00

₹0.00 (0.00%)

As on 04-Nov-2026 09:08IST

Market cap

₹65 Cr

Revenue (TTM)

₹69 Cr

P/E Ratio

--

P/B Ratio

1.2

Div. Yield

0 %

Edit

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Market cap (₹ Cr)	65	52,105	7,211	1,801	1,036
Revenue (₹ Cr)	69	6,725	7,587	137	294
Net Profit (₹ Cr)	-0.21	1,128.79	211.00	34.30	30.62
Net Margin (%)	-0.31	16.02	2.75	24.81	10.10
RoE (%)	-0.39	11.51	10.44	41.24	9.09
Price to Earnings	--	46.16	34.17	53.84	32.00
Price-To-Book	1.18	4.90	3.49	8.18	4.22

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Operating Revenue	69.47	6,430.65	6,892.47	137.42	277.86
Total Income	69.91	6,746.98	6,963.79	138.26	286.40
Total Expenditure	66.06	4,801.11	6,268.09	86.73	233.97
EBITDA	3.41	1,629.54	624.38	50.68	43.89
Depreciation	3.05	423.67	282.87	1.08	15.88
EBIT	0.36	1,205.88	341.51	49.60	28.02
Interest	1.22	33.28	137.50	3.56	1.86
Other Income	0.44	316.33	71.32	0.84	8.55
Exceptional Items	--	-24.35	--	--	-5.78
Profit before Tax	-0.42	1,464.58	275.33	46.89	28.93
Provision for Tax	-0.21	437.26	55.72	12.59	2.50
Profit after Tax	-0.21	1,027.32	219.61	34.30	26.43

Liabilities (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Shareholder's Funds	55.41	10,357.95	1,975.36	129.24	243.32
Minority Interest	--	--	-0.71	2.03	0.79
Non-Current Liabilities	7.22	482.17	1,225.00	25.98	14.83
Current Liabilities	32.53	1,608.40	763.90	27.58	30.79
Total Liabilities	95.15	12,448.52	4,084.80	184.83	300.10

Assets (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Non-Current Assets	43.88	4,921.74	1,820.29	86.31	101.01
Current Assets	51.28	7,526.79	2,143.26	98.52	188.72
Total Assets	95.15	12,448.52	4,084.80	184.83	300.10
Total Debt*	15.17	243.36	0.00	33.60	0.00
Net Current Assets	18.75	5,918.38	1,379.36	70.94	157.93
Contingent Liabilities	--	10.12	14.06	5.26	--

Cashflow (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Cash From Operating Activities	-1.49	1,031.39	495.58	10.64	-5.00
Cash Flow from Investing Activities	-4.58	137.73	-127.72	-62.70	-79.58
Cash from Financing Activities	1.50	-416.97	-255.51	61.28	-17.75
Net Cash Inflow / Outflow	-4.57	752.14	112.36	9.22	-102.33

Ratios

Profitability Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
ROCE (%)	1.15	14.96	22.22	44.38	13.29
ROE (%)	-0.39	10.56	11.93	41.24	11.95
ROA (%)	-0.23	8.70	6.00	26.21	9.31
EBIT Margin (%)	5.55	30.26	10.09	37.50	18.87
Net Margin (%)	-0.31	15.23	3.15	24.81	9.23
Cash Profit Margin (%)	4.08	22.56	7.19	25.74	15.23

Growth Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Revenue Growth (%)	12.13	14.50	12.33	78.48	16.21
EBIT Growth (%)	-66.62	31.25	26.01	99.55	14.03
Net Profit Growth (%)	-104.33	47.07	46.18	107.80	4.16
EPS Growth (%)	-104.33	47.07	45.68	54.78	-8.79
Book Value Growth (%)	-0.39	12.70	14.76	248.40	14.31

Valuation Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Price / Earnings	0.00	27.22	45.79	35.45	29.86
Price / Book Value	1.11	2.71	5.11	9.17	3.67
Dividend Yield (%)	0.00	1.18	0.00	0.00	0.00
EV/EBITDA	18.89	12.77	13.79	23.59	16.32
Market Cap (₹ Cr)	61.65	27,964.97	10,057.49	1,191.46	865.33

Solvency Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Debt to Equity	0.27	0.02	0.00	0.26	0.00
Short term debt to equity ratio	0.16	--	--	0.05	--
Current Ratio	1.58	4.68	2.81	3.57	6.13
Quick Ratio	1.15	3.60	1.00	2.82	5.42
Interest Coverage	0.66	45.01	3.00	14.19	16.57

Operating Efficiency Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Debtors to sales (%)	39.58	29.41	0.39	37.74	16.39
Asset Turnover	0.75	0.54	1.91	1.05	0.98
Receivable days	125.39	96.72	1.05	104.40	54.00
Inventory Days	79.18	97.32	71.25	45.49	26.54
Payable days	121.46	134.60	21.75	35.99	94.91
Cash Conversion Cycle	83.11	59.43	50.55	113.90	-14.37

Annual
Quarterly